Clinical Trial Update: Vaccine Therapy in Treating Patients With Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a melanoma vaccine therapy in patients with melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Melanoma vaccine therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED